LENZ$3.500.00%0.00
Lenz Therapeutics Inc (LENZ)
Date: 2026-11-04 16:00O: 3.60H: 3.70L: 3.45C: 3.46Vol: 619.1k
Lenz Therapeutics Inc stock is traded at $3.50, with a volume of 610,941. It is up 0.00% in the last 24 hours and down -2.23% over the past month. LENZ Therapeutics Inc is a late-stage biopharmaceutical company focused on developing and commercializing therapies to improve vision and developing ophthalmic pharmaceutical products. Its products VIZZ (aceclidine ophthalmic solution) 1.44% is a once-daily eye drop developed to restore clear near vision for up to 10 hours. VIZZ is powered by aceclidine, highlighted by its differentiated mechanism of action as a predominantly pupil-selective miotic that interacts with the iris, with minimal ciliary muscle stimulation.
Previous Close:
$3.50
Open:
$3.60
24h Volume:
610,941
Relative Volume:
0.39
Market Cap:
$109.97M
Revenue:
$19.09M
Net Income/Loss:
-$82.13M
P/E Ratio:
-
EPS:
-$2.80
Net Cash Flow:
-$70.00M
1W Performance:
+9.03%
1M Performance:
-2.23%
6M Performance:
-62.28%
1Y Performance:
-87.52%
1-Day Range:
$3.46$3.70
1-Week Range:
$2.80$3.73
52-Week Range:
$2.80$32.13
Lenz Therapeutics Inc Stock (LENZ) Company Profile
Name
Lenz Therapeutics IncSector
HealthcareIndustry
BiotechnologyPhone
858-925-7000Address
201 LOMAS SANTA FE DRIVE, SUITE 300, SOLANA BEACH, USAMarket Cap
Revenue
Net Income
Cash Flow
EPS
Lenz Therapeutics Inc Stock (LENZ) Upgrades & Downgrades
Lenz Therapeutics Inc Stock (LENZ) Financials Data
Lenz Therapeutics Inc Stock (LENZ) Insider Trading
- RA CAPITAL MANAGEMENT, L.P.Oct 29 '2610% Owner
- Transaction
- Sale
- Cost
- $3.36
- #Shares
- 2,718,684
- Value ($)
- 9,134,778
- #Shares Total
- 57,559
- Chevallard Daniel R.Mar 27 '26Chief Financial Officer
- Transaction
- Buy
- Cost
- $8.57
- #Shares
- 7,500
- Value ($)
- 64,275
- #Shares Total
- 12,886
- Schimmelpennink Evert B.Mar 27 '26President, CEO and Secretary
- Transaction
- Buy
- Cost
- $8.95
- #Shares
- 28,089
- Value ($)
- 251,411
- #Shares Total
- 77,289
- George Jeffrey P.Mar 27 '26Director
- Transaction
- Buy
- Cost
- $8.92
- #Shares
- 5,592
- Value ($)
- 49,890
- #Shares Total
- 5,592
- Olsson ShawnNov 17 '25Chief Commercial Officer
- Transaction
- Sale
- Cost
- $26.10
- #Shares
- 10,000
- Value ($)
- 261,022
- #Shares Total
- 4,733
- SHAWN OLSSONNov 17 '25Officer
- Transaction
- Proposed Sale
- Cost
- $25.60
- #Shares
- 40,000
- Value ($)
- 1,024,000
- #Shares Total
- 0
- Olsson ShawnNov 17 '25Chief Commercial Officer
- Transaction
- Option Exercise
- Cost
- $2.08
- #Shares
- 10,000
- Value ($)
- 20,800
- #Shares Total
- 14,733
- MCCOLLUM JAMES WNov 07 '25Director
- Transaction
- Buy
- Cost
- $22.79
- #Shares
- 10,500
- Value ($)
- 239,278
- #Shares Total
- 10,500
- Chevallard Daniel R.Nov 07 '25Chief Financial Officer
- Transaction
- Buy
- Cost
- $22.76
- #Shares
- 2,198
- Value ($)
- 50,017
- #Shares Total
- 5,386
- Versant Venture Capital VI, L.Sep 30 '2510% Owner
- Transaction
- Sale
- Cost
- $46.01
- #Shares
- 132,944
- Value ($)
- 6,117,323
- #Shares Total
- 1,050,599
